1196-65-2 Usage
Uses
Used in Pharmaceutical and Agrochemical Production:
Benzaldehyde, 4-amino-2-methoxy-, is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique chemical structure allows for the development of new drugs and pesticides with improved efficacy and reduced side effects.
Used in Organic Synthesis:
Benzaldehyde, 4-amino-2-methoxyserves as a versatile building block for the synthesis of a wide range of biologically active compounds. Its presence in organic synthesis contributes to the discovery and production of novel chemical entities with potential therapeutic and industrial applications.
Used in Food Industry:
Due to its characteristic almond-like odor, benzaldehyde, 4-amino-2-methoxy-, is employed as a flavoring agent in food products. It enhances the taste and aroma of various food items, providing a pleasant sensory experience for consumers.
Used in Perfumery and Cosmetics:
Benzaldehyde, 4-amino-2-methoxy-, is incorporated into perfumes and cosmetics as a fragrance ingredient. Its distinct almond scent adds depth and complexity to fragrance compositions, making it a valuable component in the creation of unique and appealing scents.
Check Digit Verification of cas no
The CAS Registry Mumber 1196-65-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1196-65:
(6*1)+(5*1)+(4*9)+(3*6)+(2*6)+(1*5)=82
82 % 10 = 2
So 1196-65-2 is a valid CAS Registry Number.
1196-65-2Relevant academic research and scientific papers
SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF
-
Paragraph 0889-0890, (2020/02/19)
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a 6,5-heterocyclic structure (e.g., compounds having a imidazopyridine, imidazopyrimidine, imidazopyrazine, imidazopyridazine, imidazotriazine, benzoimidazole, benzotriazole, benzoisoxazole, purine, indazole, triazolotriazine, triazolopyridazine, triazolopyrimidine, triazolopyrazine, triazolotetrazine, triazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolopyridazine, pyrazolotriazine, pyrazolopyridine, isoxazolopyrazine, isoxazolopyrimidine, isoxazolopyrdiazine, isoxazolotriazine, or isoxalopyridine structure) which function as inhibitors of DYRK1A, DYRK1B, and Clk-1, and their use as therapeutics for the treatment of Alzheimer's disease, Down syndrome, diabetes, glioblastoma, autoimmune diseases, cancer (e.g., glioblastoma, prostate cancer), inflammatory disorders (e.g., airway inflammation), and other diseases.
